What is multiple sclerosis? Multiple sclerosis is a chronic and progressive neurological disease that results in neuronal cell death, which can lead to a variety of symptoms. Find more videos at https://www.osmosis.org/product/library.
Transcript
Multiple sclerosis is a demyelinating disease of the central nervous system, which includes the brain and the spinal cord.
Myelin is the protective sheath that surrounds the axons of neurons, allowing them to quickly send electrical impulses. This myelin is produced by oligodendrocytes, which are a group of cells that support neurons.
In multiple sclerosis, demyelination happens when the immune system inappropriately attacks and destroys the myelin, which makes communication between neurons break down, ultimately leading to all sorts of sensory, motor, and cognitive problems.
Now, the brain, including the neurons in the brain, is protected by things in the blood by the blood brain barrier, which only lets certain molecules and cells through from the blood. For immune cells like T and B cells that means having the right ligand or surface molecule to get through the blood brain barrier, this is kind of like having the a VIP pass to get into an exclusive club.
Once a T cell makes its way in it can get activated by something it encounters – in the case of multiple sclerosis, it’s activated by myelin.
Once the T-cell gets activated, it changes the blood brain barrier cells to express more receptors, and this allows immune cells to more easily bind and get in, it’s kind of like bribing the bouncer to let in a lot of people.
Now, multiple sclerosis is a type IV hypersensitivity reaction, or cell-mediated hypersensitivity. And this means that those myelin specific T-cells release cytokines like IL-1, IL-6, TNF-alpha, and interferon-gamma, and together dilate the blood vessels which allows more immune cells to get in, as well as directly cause damage to the oligodendrocytes.
They cytokines also attract B-cells and macrophages as part of the inflammatory reaction. Those B-cells begin to make antibodies that mark the myelin sheath proteins, and then the macrophages use those antibody markers to engulf and destroy the oligodendrocytes.
Without oligodendrocytes, there’s no myelin to cover the neurons, and this leaves behind areas of scar tissue, also called plaques or sclera. In multiple sclerosis, these immune attacks typically happen in bouts. In other words, an autoimmune attack on the oligodendrocytes might happen, and then regulatory T cells will come in to inhibit or calm down the other immune cells, leading to a reduction in the inflammation.
Early on in multiple sclerosis, the oligodendrocytes will heal and extend out new myelin to cover the neurons, which is a process called remyelination. Unfortunately, though, over time as the oligodendrocytes die off the remyelination stops and the damage becomes irreversible with the loss of axons. Just like other autoimmune diseases, the exact cause of multiple sclerosis is unknown, but is linked to both genetic and environmental factors.
- Genetic risk factors include being a woman and having genes that encode a specific type of immune molecule called HLA-DR2 which is used to identify and bind to foreign molecules.
- Environmental risk factors might include infections as well as vitamin D deficiency, which is an interesting one because it might help explain why the rates of multiple sclerosis are higher at the northern and southern poles compared to the equator where there’s a lot more sunlight.
Together these genetic and environmental influences might lead to the body not killing off immune cells that target myelin. So it turns out that there are four main types of multiple sclerosis based on the pattern of symptoms over time.
To break this down, we can use this graph with time on the x-axis, where time refers to the lifespan of the individual, and disability on the y-axis.
- The first, and by far the most common pattern of multiple sclerosis, is called relapsing-remitting multiple sclerosis or RRMS. This condition is what we just described, bouts of autoimmune attacks happening months, or even years, apart, and causing an increase in the level of disability. For example, during a bout a person may lose some vision, but then it may be followed by improvement if there’s remyelination. Unfortunately, though, more often than not, the remyelination process is not complete so there is often some residual disability that remains, and that means that with each attack, more and more of the central nervous system gets irreversibly damaged. In the relapsing-remitting multiple sclerosis type there’s typically no increase in disability between bouts, so the line stays flat during that time.
- Now, the second type is called secondary progressive multiple sclerosis or SPMS which initially is pretty similar to the relapse-remitting type, but over time the immune attack becomes constant which causes a steady progression of disability.
- The third type is primary-progressive multiple sclerosis or PPMS, which is basically one constant attack on myelin which causes a steady progression of disability over a person’s lifetime.
- The final type is progressive relapsing multiple sclerosis or PRMS, which is also one constant attack but this time there are bouts superimposed during which the disability increases even faster.
Specific symptoms varying a lot from person to person, and largely depend on the location of the plaques. And multiple sclerosis typically affects individuals between the ages of 20 and 40.
Symptoms related to bouts can typically worsen over weeks and can linger for months without treatment.
One common trio of multiple sclerosis symptoms is called Charcot’s neurologic triad and it includes dysarthria, which is difficulty or unclear speech, nystagmus, which is involuntary rapid eye movements, and an intention tremor.
Dysarthria is due to plaques in the brainstem that affect nerve fibers that control muscles of the mouth and throat, and this can interfere with conscious movements, like eating and talking and can lead to things like a new stutter, as well as unconscious movements, like swallowing.
Nystagmus is due to plaques around the nerves controlling eye movements. Plaques around the optic nerve causes loss of vision in one or both of the eyes because of damage to the optic nerve, which is called optic neuritis.
Sometimes there’s blurring or graying of the vision, or alternatively there might be a dark point in the center of vision.
Additionally, if there’s damage to the nerves controlling eye movement, then eye movements can be painful and there can even be double vision, if the eyes can no longer move in a coordinated way.
Finally, intention tremors can be caused by plaques along the motor pathways in the spinal cord which can affect outbound signals like skeletal muscle control.
Motor symptoms can include muscle weakness, muscle spasms, tremors, and ataxia, which is a loss of balance and coordination. In serious cases, this can lead to paralysis.
In addition, plaques in the sensory pathways can affect inbound signals like sensations from the skin which causes symptoms like numbness, pins-and-needles, and paresthesias which are often a tingling feeling but may also be a painful itching or burning sensation.
Occasionally there can be very specific sensory symptoms like Lhermitte’s sign, which is when an electric shock runs down the back and radiates to the limbs when a person bends their neck forward.
Plaques can also involve the autonomic nervous system which can lead to bowel and bladder symptoms like constipation and urinary incontinence, as well as sexual symptoms like sexual dysfunction.
Finally, multiple sclerosis can also affect higher order activities of the brain, causing poor concentration and critical thinking, as well as depression and anxiety.
Multiple sclerosis is typically suspected when there are multiple neurologic symptoms separated in space, which is attributable to damage in different locations in the nervous system, as well as time, meaning separate bouts or flare-ups as well as remission.
The diagnosis of multiple sclerosis is supported by an MRI which shows multiple central nervous system lesions, called white matter plaques, since these regions tend to have lots of myelin. Also, in the cerebrospinal fluid there might be high levels of antibodies, which indicates an autoimmune process.
Finally a visual evoked potential can be helpful as well, which measures the nervous system’s response to visual stimuli.
For treatment, there is no cure for multiple sclerosis, but there are medications which are particularly effective for the relapsing-remitting type because they lessen the severity of relapses and make them happen less frequently. Medications like corticosteroids, cyclophosphamide which is a cell cycle inhibitor, and intravenous immunoglobulin can all be used to help blunt the autoimmune process.
In addition, plasmapheresis can be effective as well, which is when the plasma is filtered to remove disease-causing autoantibodies.
Chronic treatment for multiple sclerosis includes immunosuppressants like recombinant beta-IFN which decreases the level of inflammatory cytokines in the brain and increases the function of T regulatory cells.
Other immunosuppressants actually block T cells from getting into the brain by interfering with their cell surface molecules they use to gain passage through the blood brain barrier.
Unfortunately, though, there are fewer treatment options available for the progressive MS.
Instead, treatments are often targeted at managing specific symptoms—everything ranging from depression to bladder dysfunction. Physical therapy and cognitive rehabilitation therapy can be particularly helpful with sensory, motor, and cognitive symptoms.
Finally, there’s also an increasing interest in the role of vitamin D as an effective treatment.
All right, as a quick recap, multiple sclerosis is a chronic and progressive autoimmune disorder, and the most common pattern is the relapsing-remitting type, where individuals have flares that come and go, with each one slightly worsening their overall condition. During a flare, T-cells cause inflammation and damage to oligodendrocytes in the central nervous system, which leaves behind scarred areas of demyelinated neurons called plaques, which causes a variety of symptoms depending on the location.
 logo final copy.png)
- New study challenges social media’s mental health impact - 21st November 2024
- Do Finland introduces a new care pathway for epilepsy - 21st November 2024
- Innovative swim program for people with cerebral palsy - 21st November 2024
